within Pharmacolibrary.Drugs.ATC.L;

model L03AC02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 4.6666666666666666e-07,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 8.999999999999999e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L03AC02</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oprelvekin (recombinant interleukin-11) is a thrombopoietic growth factor used to stimulate the production of platelets in patients undergoing chemotherapy for non-myeloid malignancies. It was approved to reduce the incidence of severe thrombocytopenia and the need for platelet transfusions, but its use is limited due to safety concerns related to fluid retention and cardiac events.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data in patients with cancer; typical population included adults administered subcutaneous oprelvekin after chemotherapy.</p><h4>References</h4><ol><li><p>Cotreau, MM, et al., &amp; Schwertschlag, US (2004). A multiple-dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin). <i>Biopharmaceutics &amp; drug disposition</i> 25(7) 291–296. DOI:<a href=\"https://doi.org/10.1002/bdd.415\">10.1002/bdd.415</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15386478/\">https://pubmed.ncbi.nlm.nih.gov/15386478</a></p></li><li><p>Jung, Y, et al., &amp; Kim, S (2011). Improvement of biological and pharmacokinetic features of human interleukin-11 by site-directed mutagenesis. <i>Biochemical and biophysical research communications</i> 405(3) 399–404. DOI:<a href=\"https://doi.org/10.1016/j.bbrc.2011.01.041\">10.1016/j.bbrc.2011.01.041</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21238428/\">https://pubmed.ncbi.nlm.nih.gov/21238428</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L03AC02;
